BioCryst to Present at Upcoming Investor Conference
-3d
Management Change/Compensation (Form 8-K)
-5d
Statement of Changes in Beneficial Ownership (Form 4)
3/19
Annual Report for Fiscal Year Ending 12-31, 2024 (Form 10-K)
3/18
Statement of Changes in Beneficial Ownership (Form 4)
2/4
Management Change/Compensation Form 8 K
-3m
Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
-4m
Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)
-7m
Statement of Changes in Beneficial Ownership - Form 4
-9m
Statement of Changes in Beneficial Ownership - Form 4
-9m